Making Sense of Statistics in Clinical Trial Reports Part 1 of a 4-Part Series on Statistics for Clinical Trials

Journal of the American College of Cardiology

Volumn 66, Issue 22, 2015, Pages 2536-2549

  Pocock, Stuart J ^a   McMurray, John J V ^b   Collier, Tim J ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

interpretation; Key Words clinical trials; publication; statistics

Indexed keywords

CLOPIDOGREL; ENALAPRIL; SACUBITRIL PLUS VALSARTAN; TICAGRELOR;

ADULT; ARTICLE; CARDIOVASCULAR RISK; COMPARATIVE EFFECTIVENESS; CONFIDENCE INTERVAL; DATA ANALYSIS; EVIDENCE BASED MEDICINE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT PRECISION; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; STATISTICAL ANALYSIS; SYSTOLIC BLOOD PRESSURE; CLINICAL TRIAL (TOPIC); INFORMATION PROCESSING;

CLINICAL TRIALS AS TOPIC; DATA DISPLAY; DATA INTERPRETATION, STATISTICAL; HUMANS;

EID: 84962231193     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.10.014     Document Type: Review

References (26)

1. J.J.V. McMurray, M. Packer, A.S. Desai, and et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure N Engl J Med 371 2014 993 1004
2. B.M. Scirica, D.L. Bhatt, E. Braunwald, and et al. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus N Engl J Med 369 2013 1317 1326
3. J. Kjekshus, E. Apetrei, V. Barrios, and et al. Rosuvastatin in older patients with systolic heart failure N Engl J Med 357 2007 2248 2261
4. J.K. Rogers, P.S. Jhund, A.-C. Perez, and et al. Effect of rosuvastatin on repeat heart failure hospitalizations: the CORONA trial (Controlled Rosuvastatin Multinational Trial in Heart Failure) J Am Coll Cardiol HF 2 2014 289 297
5. L. Wallentin, R.C. Becker, A. Budaj, and et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
6. S.J. Pocock, T.C. Clayton, and D.G. Altman Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls Lancet 359 2002 1686 1689
7. D. Moher, S. Hopewell, K.F. Schulz, and et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials BMJ 340 2010 c869
8. A. Shahzad, I. Kemp, C. Mars, and et al. Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial Lancet 384 2014 1849 1858
9. D.L. Bhatt, G.W. Stone, K.W. Mahaffey, and et al. Effect of platelet inhibition with cangrelor during PCI on ischemic events N Engl J Med 368 2013 1303 1313
10. C.J. Bulpitt Confidence intervals Lancet 329 1987 494 497
11. D. Altman, D. Machin, T. Bryant, and M. Gardner Statistics with confidence: confidence intervals and statistical guidelines 2013 John Wiley & Sons Hoboken, NJ
12. T. Clark, M. Bradburn, S. Love, and D. Altman Survival analysis part I: basic concepts and first analyses Br J Cancer 89 2003 232
13. M.E. Farkouh, M. Domanski, L.A. Sleeper, and et al. Strategies for multivessel revascularization in patients with diabetes N Engl J Med 367 2012 2375 2384
14. L. Wei The accelerated failure time model: a useful alternative to the Cox regression model in survival analysis Stat Med 11 1992 1871 1879
15. F. Zannad, J.J.V. McMurray, H. Krum, and et al. Eplerenone in patients with systolic heart failure and mild symptoms N Engl J Med 364 2011 11 21
16. A.J. Vickers, and D.G. Altman Analysing controlled trials with baseline and follow up measurements BMJ 323 2001 1123 1124
17. D.L. Bhatt, D.E. Kandzari, W.W. O'Neill, and et al. A controlled trial of renal denervation for resistant hypertension N Engl J Med 370 2014 1393 1401
18. S. Senn Change from baseline and analysis of covariance revisited Stat Med 25 2006 4334 4344
19. S.J. Pocock, and J.H. Ware Translating statistical findings into plain English Lancet 373 2009 1926 1928
20. C.P. Cannon, M.A. Blazing, R.P. Giugliano, and et al. Ezetimibe added to statin therapy after acute coronary syndromes N Engl J Med 372 2015 2387 2397
21. M. Gheorghiade, M. Böhm, S.J. Greene, and et al. Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial JAMA 309 2013 1125 1135
22. J.A. Sterne, and G. Davey Smith Sifting the evidence - what's wrong with significance tests? BMJ 322 2001 226 231
23. G.W. Stone, and S.J. Pocock Randomized trials, statistics, and clinical inference J Am Coll Cardiol 55 2010 428 431
24. D.H. Adams, J.J. Popma, M.J. Reardon, and et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis N Engl J Med 370 2014 1790 1798
25. M. Tepel, M. van der Giet, C. Schwarzfeld, and et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine N Engl J Med 343 2000 180 184
26. S.J. Pocock The simplest statistical test: how to check for a difference between treatments BMJ 332 2006 1256 1258